[1] |
BRAY F, FERLAY J, SOERJOMATARAM I,et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424. DOI: 10.3322/caac.21492.
|
[2] |
CHEN B X, WANG L M, REN C,et al. The effect of neoadjuvant chemotherapy on lymph node metastasis of FIGO stage ⅠB1-ⅡB cervical cancer:a systematic review and meta-analysis[J]. Front Oncol, 2020, 10:570258. DOI: 10.3389/fonc.2020.570258.
|
[3] |
WIDSCHWENDTER P, JANNI W, SCHOLZ C,et al. Prognostic factors for and pattern of lymph-node involvement in patients with operable cervical cancer[J]. Arch Gynecol Obstet, 2019, 300(6):1709-1718. DOI: 10.1007/s00404-019-05341-3.
|
[4] |
BUJNAK A C, TEWARI K S. Should adjuvant chemotherapy be formally studied among patients found to have pelvic lymph node metastases following radical hysterectomy with lymphadenectomy for early-stage cervical cancer?[J]. J Gynecol Oncol, 2021, 32(4):e62. DOI: 10.3802/jgo.2021.32.e62.
|
[5] |
KILIC C, KIMYON COMERT G, CAKIR C,et al. Recurrence pattern and prognostic factors for survival in cervical cancer with lymph node metastasis[J]. J Obstet Gynaecol Res, 2021, 47(6):2175-2184. DOI: 10.1111/jog.14762.
|
[6] |
ZHAO W C, YANG Q. Lymph-vascular space invasion in patients with stages IA2-IIA2 cervical cancer treated with laparoscopic versus open radical hysterectomy[J]. Cancer Manag Res, 2021, 13:1179-1186. DOI: 10.2147/CMAR.S292477.
|
[7] |
MCCOMAS K N, TORGESON A M, AGER B J,et al. The variable impact of positive lymph nodes in cervical cancer:implications of the new FIGO staging system[J]. Gynecol Oncol, 2020, 156(1):85-92. DOI: 10.1016/j.ygyno.2019.10.025.
|
[8] |
|
[9] |
|
[10] |
|
[11] |
XIAO M, MA F, LI Y,et al. Multiparametric MRI-based radiomics nomogram for predicting lymph node metastasis in early-stage cervical cancer[J]. J Magn Reson Imaging, 2020, 52(3):885-896. DOI: 10.1002/jmri.27101.
|
[12] |
|
[13] |
|
[14] |
CAPOZZI V A, SOZZI G, MONFARDINI L,et al. Transperitoneal versus extraperitoneal laparoscopic aortic lymph nodal staging for locally advanced cervical cancer:a systematic review and meta-analysis[J]. Eur J Surg Oncol, 2021, 47(9):2256-2264. DOI: 10.1016/j.ejso.2021.04.036.
|
[15] |
|
[16] |
FERRANDINA G, PEDONE ANCHORA L, GALLOTTA V,et al. Can we define the risk of lymph node metastasis in early-stage cervical cancer patients? A large-scale,retrospective study[J]. Ann Surg Oncol, 2017, 24(8):2311-2318. DOI: 10.1245/s10434-017-5917-0.
|
[17] |
MATHEVET P, LÉCURU F, UZAN C,et al. Sentinel lymph node biopsy and morbidity outcomes in early cervical cancer:Results of a multicentre randomised trial (SENTICOL-2)[J]. Eur J Cancer, 2021, 148:307-315. DOI: 10.1016/j.ejca.2021.02.009.
|
[18] |
FAVRE G, GUANI B, BALAYA V,et al. Sentinel lymph-node biopsy in early-stage cervical cancer:the 4-year follow-up results of the senticol 2 trial[J]. Front Oncol, 2020, 10:621518. DOI: 10.3389/fonc.2020.621518.
|
[19] |
ROB L, LUKAS R, ROBOVA H,et al. Current status of sentinel lymph node mapping in the management of cervical cancer[J]. Expert Rev Anticancer Ther, 2013, 13(7):861-870. DOI: 10.1586/14737140.2013.811147.
|
[20] |
CIBULA D, BORCINOVÁ M, MARNITZ S,et al. Lower-limb lymphedema after sentinel lymph node biopsy in cervical cancer patients[J]. Cancers (Basel), 2021, 13(10):2360. DOI: 10.3390/cancers13102360.
|
[21] |
YA X, QIAN W, HUIQING L,et al. Role of carbon nanoparticle suspension in sentinel lymph node biopsy for early-stage cervical cancer:a prospective study[J]. BJOG, 2021, 128(5):890-898. DOI: 10.1111/1471-0528.16504.
|
[22] |
BIZZARRI N, LUIGI P A, FERRANDINA G,et al. Sentinel lymph node mapping with indocyanine green in cervical cancer patients undergoing open radical hysterectomy:a single-institution series[J]. J Cancer Res Clin Oncol, 2021, 147(3):649-659. DOI: 10.1007/s00432-020-03393-6.
|
[23] |
ZHANG X Y, BAO B T, WANG S X,et al. Sentinel lymph node biopsy in early stage cervical cancer:a meta-analysis[J]. Cancer Med, 2021, 10(8):2590-2600. DOI: 10.1002/cam4.3645.
|
[24] |
|
[25] |
SMITS R M, ZUSTERZEEL P L, BEKKERS R L. Pretreatment retroperitoneal Para-aortic lymph node staging in advanced cervical cancer:a review[J]. Int J Gynecol Cancer, 2014, 24(6):973-983. DOI: 10.1097/IGC.0000000000000177.
|
[26] |
LIU J P, LIU X, GUO Z Y,et al. Ultrasound-guided fine needle aspiration cytology of Para-aortic lymph node metastasis in uterine cervical cancer:diagnostic accuracy and impact on clinical decision making[J]. BMC Cancer, 2021, 21(1):964. DOI: 10.1186/s12885-021-08492-2.
|
[27] |
YANG J, DELARA R, MAGRINA J,et al. Comparing survival outcomes between surgical and radiographic lymph node assessment in locally advanced cervical cancer:a propensity score-matched analysis[J]. Gynecol Oncol, 2020, 156(2):320-327. DOI: 10.1016/j.ygyno.2019.12.009.
|
[28] |
MARTINEZ A, ANGELES M A, QUERLEU D,et al. How should we stage and tailor treatment strategy in locally advanced cervical cancer? Imaging versus Para-aortic surgical staging[J]. Int J Gynecol Cancer, 2020, 30(9):1434-1443. DOI: 10.1136/ijgc-2020-001351.
|
[29] |
|
[30] |
CIBULA D, DOSTALEK L, HILLEMANNS P,et al. Completion of radical hysterectomy does not improve survival of patients with cervical cancer and intraoperatively detected lymph node involvement:ABRAX international retrospective cohort study[J]. Eur J Cancer, 2021, 143:88-100. DOI: 10.1016/j.ejca.2020.10.037.
|